Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells
-
Published:2022-07-28
Issue:8
Volume:23
Page:1256-1272
-
ISSN:1529-2908
-
Container-title:Nature Immunology
-
language:en
-
Short-container-title:Nat Immunol
Author:
Csomos Krisztian, Ujhazi Boglarka, Blazso PeterORCID, Herrera Jose L., Tipton Christopher M., Kawai Tomoki, Gordon Sumai, Ellison Maryssa, Wu Kevin, Stowell Matthew, Haynes LaurenORCID, Cruz Rachel, Zakota Bence, Nguyen Johnny, Altrich Michelle, Geier Christoph B.ORCID, Sharapova Svetlana, Dasso Joseph F.ORCID, Leiding Jennifer W., Smith GraceORCID, Al-Herz WaleedORCID, de Barros Dorna MayraORCID, Fadugba Olajumoke, Fronkova Eva, Kanderova Veronika, Svaton MichaelORCID, Henrickson Sarah E., Hernandez Joseph D., Kuijpers Taco, Kandilarova Snezhina Mihailova, Naumova Elizaveta, Milota Tomas, Sediva Anna, Moshous DespinaORCID, Neven Benedicte, Saco Tara, Sargur Ravishankar, Savic Sinisa, Sleasman John, Sunkersett Gauri, Ward Brant R., Komatsu Masanobu, Pittaluga StefaniaORCID, Kumanovics Attila, Butte Manish J.ORCID, Cancro Michael P., Pillai ShivORCID, Meffre EricORCID, Notarangelo Luigi D.ORCID, Walter Jolan E.ORCID
Abstract
AbstractThe recombination-activating genes (RAG) 1 and 2 are indispensable for diversifying the primary B cell receptor repertoire and pruning self-reactive clones via receptor editing in the bone marrow; however, the impact ofRAG1/RAG2on peripheral tolerance is unknown. Partial RAG deficiency (pRD) manifesting with late-onset immune dysregulation represents an ‘experiment of nature’ to explore this conundrum. By studying B cell development and subset-specific repertoires in pRD, we demonstrate that reduced RAG activity impinges on peripheral tolerance through the generation of a restricted primary B cell repertoire, persistent antigenic stimulation and an inflammatory milieu with elevated B cell-activating factor. This unique environment gradually provokes profound B cell dysregulation with widespread activation, remarkable extrafollicular maturation and persistence, expansion and somatic diversification of self-reactive clones. Through the model of pRD, we reveal aRAG-dependent ‘domino effect’ that impacts stringency of tolerance and B cell fate in the periphery.
Funder
Jeffrey Modell Foundation U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases Robert A. Good Endowment, University of South Florida Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference67 articles.
1. Oettinger, M. A., Schatz, D. G., Gorka, C. & Baltimore, D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517–1523 (1990). 2. Lee, Y. N. et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J. Allergy Clin. Immunol. 133, 1099–1108 (2014). 3. Lawless, D. et al. Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. J. Allergy Clin. Immunol. 141, 2303–2306 (2018). 4. Notarangelo, L. D., Kim, M. S., Walter, J. E. & Lee, Y. N. Human RAG mutations: biochemistry and clinical implications. Nat. Rev. Immunol. 16, 234–246 (2016). 5. Walter, J. E. et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J. Clin. Invest. 125, 4135–4148 (2015).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|